VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 1, 2026
Stock Comparison
HCA Healthcare, Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
HCA Healthcare, Inc.
HCA · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into HCA Healthcare, Inc.'s moat claims, evidence, and risks.
View HCA analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 67 / 100 for HCA Healthcare, Inc.).
- Segment focus: HCA Healthcare, Inc. has 1 segment (100% in Hospitals and related healthcare entities); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: HCA Healthcare, Inc. has 4 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
HCA Healthcare, Inc.
Hospitals and related healthcare entities
Acute care hospitals and outpatient healthcare services
United States (multi-state) and England (United Kingdom)
Patients and third-party payers
Provider operator
100%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
HCA Healthcare, Inc. strengths
Novo Nordisk A/S strengths
Segment mix
HCA Healthcare, Inc. segments
Full profile >Hospitals and related healthcare entities
Oligopoly
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.